Related Articles
MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer
Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
Circulating miR‑141‑3p, miR‑143‑3p and miR‑200c‑3p are differentially expressed in colorectal cancer and advanced adenomas
Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer
Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer